VENETOCLAX

1 FDA products 1 manufacturers ORAL

VENETOCLAX is an active ingredient listed in 1 FDA drug label records from 1 manufacturers taken by oral route marketed mainly as human prescription drug products.

About VENETOCLAX

VENETOCLAX appears as the active ingredient in 1 FDA drug label records. These products are produced by 1 distinct manufacturers, with the largest catalogues from AbbVie Inc.. In this ingredient’s product set, the most common route of administration is oral. Approved labelling for these products most frequently references: chronic lymphocytic, acute myeloid, treatment adult, leukemia cll, lymphoma sll, azacitidine decitabine, low-dose cytarabine, newly diagnosed. Every record below is taken from FDA Structured Product Labelling data; use it to compare brand names, strengths and manufacturers before speaking with a pharmacist.

How it is supplied

Dosage formProductsRouteProducts
— — ORAL 1
— — — —
— — — —
— — — —
— — — —
— — — —

Main manufacturers

ManufacturerProductsMarketing type
AbbVie Inc. 1 HUMAN PRESCRIPTION DRUG

FDA drug products containing VENETOCLAX

Brand nameManufacturerTypeRouteDosage form
Venclexta AbbVie Inc. HUMAN PRESCRIPTION DRUG ORAL

Frequently asked questions

How many FDA drug products contain VENETOCLAX?
1 FDA drug label records list VENETOCLAX as the active ingredient, supplied by 1 manufacturers. The table below lists the brand names, manufacturers and dosage forms covered by those labels.

Which companies make VENETOCLAX products?
The manufacturers with the most VENETOCLAX label records are AbbVie Inc.. Generic and brand versions may be produced by different companies.

Is this a substitute for medical advice?
No. This page reproduces FDA labelling data so you can identify a product and its manufacturer. Dosing, interactions and suitability must be confirmed with a prescriber or pharmacist.

This page reproduces FDA Structured Product Labelling data for identification purposes. It is not medical advice and does not recommend, sell or price any medicine.